Sartorius Stedim Biotech header image

Sartorius Stedim Biotech

DIM

Equity

ISIN FR0013154002 / Valor 32518471

Euronext - Euronext Paris (2026-04-28)
EUR 156.80-1.82%

Sartorius Stedim Biotech
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Sartorius Stedim Biotech is a prominent global player in the biopharmaceutical industry, specializing in the development and manufacturing of biotech medications and vaccines. With a workforce of approximately 9,900 employees and operations in over 30 countries, the company provides a comprehensive range of products and technologies that support all critical stages of biopharmaceutical production and process development. Its offerings include cell line technologies, cell culture media, bioreactors, and various solutions for the separation, purification, and concentration of biological intermediates and finished products, as well as their storage and transportation. Headquartered in Aubagne, France, Sartorius Stedim Biotech is a subsidiary of Sartorius AG, which holds a significant majority of its share capital and voting rights. The company is publicly traded on the Euronext stock exchange in Paris.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-21.8%1Y
-35.3%3Y
-58.6%5Y

Performance

37.9%1Y
44.3%3Y
43.4%5Y

Volatility

Market cap

17852 M

Market cap (USD)

Daily traded volume (Shares)

111,847

Daily traded volume (Shares)

1 day high/low

187.35 / 183.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Progyny Inc
Progyny Inc Progyny Inc Valor: 50342281
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.16%USD 18.38
Baxter International Inc
Baxter International Inc Baxter International Inc Valor: 911702
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.97%USD 17.94
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.88%EUR 366.00
Amphastar Pharmaceuticals Inc
Amphastar Pharmaceuticals Inc Amphastar Pharmaceuticals Inc Valor: 24511852
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.79%USD 21.82
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.40%USD 24.96
Interparfums
Interparfums Interparfums Valor: 86977
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.66%EUR 24.00
Guardant Health Inc
Guardant Health Inc Guardant Health Inc Valor: 43633454
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.11%USD 83.09
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.25%USD 67.51
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.89%USD 3.89
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc Edgewise Therapeutics Inc Valor: 110444153
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.14%USD 30.99